China SXT Pharmaceuticals, Inc.
SXTC
$2.16
$1.17118.43%
NASDAQ
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 5.80M | 1.35M | -3.10M | -8.62M | -14.14M |
| Total Depreciation and Amortization | 169.00K | 186.10K | 203.20K | 223.10K | 243.00K |
| Total Amortization of Deferred Charges | 168.40K | 230.60K | 292.80K | 264.80K | 236.80K |
| Total Other Non-Cash Items | -7.39M | -3.17M | 1.06M | 6.56M | 12.06M |
| Change in Net Operating Assets | -1.44M | -912.70K | -381.60K | 551.60K | 1.48M |
| Cash from Operations | -2.71M | -2.32M | -1.93M | -1.02M | -111.20K |
| Capital Expenditure | -7.00K | -7.00K | -7.00K | -28.80K | -50.60K |
| Sale of Property, Plant, and Equipment | 40.60K | 20.30K | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 13.80K | 23.60K | 33.40K | 26.00K | 18.60K |
| Cash from Investing | 47.40K | 36.90K | 26.40K | -2.80K | -32.00K |
| Total Debt Issued | 8.76M | 5.13M | 1.50M | 2.83M | 4.16M |
| Total Debt Repaid | 497.00K | -1.76M | -4.01M | -190.60K | 3.63M |
| Issuance of Common Stock | -- | -- | -- | 1.10M | 2.19M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -178.00K | -144.20K | -110.40K | -271.10K | -431.80K |
| Cash from Financing | 9.07M | 3.23M | -2.62M | 3.46M | 9.55M |
| Foreign Exchange rate Adjustments | 631.60K | -66.80K | -765.20K | -843.60K | -922.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 7.05M | 878.30K | -5.29M | 1.60M | 8.48M |